ArticleFrontiers in neurology2024

Transcranial photobiomodulation in children aged 2-6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology.

Yuliy Fradkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.